{"id":"https://openalex.org/W1889354068","doi":null,"title":"Standardizing assessment of adverse effects in rheumatology clinical trials. Status of OMERACT Toxicity Working Group March 2000: towards a common understanding of comparative toxicity/safety profiles for antirheumatic therapies.","display_name":"Standardizing assessment of adverse effects in rheumatology clinical trials. Status of OMERACT Toxicity Working Group March 2000: towards a common understanding of comparative toxicity/safety profiles for antirheumatic therapies.","publication_year":2001,"publication_date":"2001-05-01","ids":{"openalex":"https://openalex.org/W1889354068","mag":"1889354068","pmid":"https://pubmed.ncbi.nlm.nih.gov/11361207"},"language":"en","primary_location":{"id":"pmid:11361207","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11361207","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of rheumatology","raw_type":"Consensus Statement"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071494532","display_name":"THASIA G. WOODWORTH","orcid":"https://orcid.org/0000-0002-6760-7451","observed_orcids":["https://orcid.org/0000-0002-6760-7451"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T G Woodworth","raw_affiliation_strings":["Pfizer Groton R & D, Groton, CT, USA. thasia_g_woodworth@groton.pfizer.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Groton R & D, Groton, CT, USA. thasia_g_woodworth@groton.pfizer.com","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110384918","display_name":"Daniel E Furst","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D E Furst","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012283576","display_name":"Vibeke Strand","orcid":"https://orcid.org/0000-0003-4978-4072","observed_orcids":["https://orcid.org/0000-0003-4978-4072"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V Strand","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028106526","display_name":"Joachim Kempeni","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Kempeni","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113742803","display_name":"Helmut Fenner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Fenner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004488408","display_name":"Chak Sing Lau","orcid":"https://orcid.org/0000-0001-6698-8355","observed_orcids":["https://orcid.org/0000-0001-6698-8355"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C S Lau","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046727318","display_name":"Frederick W. Miller","orcid":"https://orcid.org/0000-0003-2831-9593","observed_orcids":["https://orcid.org/0000-0003-2831-9593"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F Miller","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067007569","display_name":"Richard Osborne Day","orcid":"https://orcid.org/0000-0002-6045-6937","observed_orcids":["https://orcid.org/0000-0002-6045-6937"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Day","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015496399","display_name":"John A. Lipani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Lipani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5030544708","display_name":"Peter Brooks","orcid":"https://orcid.org/0000-0001-7733-7750","observed_orcids":["https://orcid.org/0000-0001-7733-7750","https://orcid.org/0000-0003-4915-4986"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Brooks","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.5139,"has_fulltext":false,"cited_by_count":34,"citation_normalized_percentile":{"value":0.77213749,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"28","issue":"5","first_page":"1163","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.8413000106811523,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.8413000106811523,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.08640000224113464,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.05820000171661377,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adverse-event-reporting","display_name":"adverse event reporting","score":0.7689999938011169},{"id":"https://openalex.org/keywords/toxicity-assessment","display_name":"toxicity prediction","score":0.6600000262260437},{"id":"https://openalex.org/keywords/antirheumatic-drugs","display_name":"antirheumatic drugs","score":0.7490000128746033},{"id":"https://openalex.org/keywords/adverse-event-severity","display_name":"adverse event severity","score":0.4659999907016754},{"id":"https://openalex.org/keywords/common-terminology","display_name":"common terminology","score":0.6549999713897705},{"id":"https://openalex.org/keywords/post-marketing-surveillance","display_name":"post-marketing surveillance","score":0.9350000023841858},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5440000295639038}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9537085294723511},{"id":"https://openalex.org/C198451711","wikidata":"https://www.wikidata.org/wiki/Q327657","display_name":"Rheumatology","level":2,"score":0.7799091339111328},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.7318089008331299},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.6513221859931946},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6335382461547852},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.4550860524177551},{"id":"https://openalex.org/C2777793932","wikidata":"https://www.wikidata.org/wiki/Q1116229","display_name":"Common Terminology Criteria for Adverse Events","level":3,"score":0.4295429587364197},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3965464234352112},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.36935684084892273}],"mesh":[{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012216","descriptor_name":"Rheumatic Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012219","descriptor_name":"Rheumatology","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":true},{"descriptor_ui":"D017410","descriptor_name":"Practice Guidelines as Topic","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":false},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:11361207","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11361207","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of rheumatology","raw_type":"Consensus Statement"},{"id":"mag:1889354068","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11361207","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1830490643","https://openalex.org/W2987542863","https://openalex.org/W2474285900","https://openalex.org/W2754780777","https://openalex.org/W2162721989","https://openalex.org/W1901146240","https://openalex.org/W7143357207","https://openalex.org/W4245757826","https://openalex.org/W2417580273","https://openalex.org/W2943059628"],"abstract_inverted_index":{"This":[0],"paper":[1],"describes":[2],"the":[3,15,29,49,73],"background":[4],"and":[5,47,61,85,96],"current":[6],"status":[7],"of":[8,17,31,44,51,54],"an":[9,32],"OMERACT":[10],"facilitated":[11],"effort":[12],"to":[13,99],"improve":[14,48],"consistency":[16,50],"adverse":[18,33],"event":[19,34],"reporting":[20,52],"in":[21,102],"rheumatology":[22,58],"clinical":[23,59,103],"trials.":[24,104],"The":[25,65],"overall":[26],"goal":[27],"is":[28,90],"development":[30],"assessment":[35],"tool":[36,89],"that":[37],"would":[38],"provide":[39],"a":[40],"basis":[41],"for":[42],"use":[43],"common":[45],"terminology":[46],"severity":[53],"side":[55],"effects":[56],"within":[57],"trials":[60],"during":[62],"postmarketing":[63],"surveillance.":[64],"resulting":[66],"Rheumatology":[67],"Common":[68],"Toxicity":[69],"Criteria":[70],"Index":[71],"encompassed":[72],"following":[74],"organ":[75],"systems:":[76],"allergic/immunologic,":[77],"cardiac,":[78],"ENT,":[79],"gastrointestinal,":[80],"musculoskeletal,":[81],"neuropsychiatric,":[82],"ophthalmologic,":[83],"pulmonary":[84],"skin/integument.":[86],"Before":[87],"this":[88],"widely":[91],"accepted,":[92],"its":[93],"validity,":[94],"consistency,":[95],"feasibility":[97],"need":[98],"be":[100],"assessed":[101]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}